Dr. Michael Dylan Greicius, MD

Dr. Greicius practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Greicius' NPI, 1861443509, was assigned on May 15, 2006. Dr. Greicius graduated from Vagelos College of Physicians and Surgeons in 1996. Dr. Greicius holds California license A73822.

Dr. Greicius' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Greicius' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Greicius to 1 more hospital, named with a free account. Dr. Greicius' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greicius practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Greicius' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Greicius is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Greicius is licensed in California.

Dmand AI lists alzheimer's disease and non-alzheimer's dementia (chronic) among the conditions Dr. Greicius treats.

CMS data shows 58 Medicare services from Dr. Greicius across 2 procedure codes in 2024, all of them office visits, for 63 Medicare patients. Medicare paid $6,030 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Greicius in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have alzheimer's and dementia, and 65% have high cholesterol. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Greicius' median patient age at 80, with 43% women.

In 2024, Dr. Greicius wrote 227 Medicare Part D claims for 46 patients. 100% of them were for generic drugs. CMS names the drug for 221 of them, across 8 drugs with 11 or more claims each, at $10,890 in total drug cost. In 2023, CMS named 189 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Greicius for performance year 2024, reported as part of a group. Dr. Greicius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Greicius as offering telehealth.

Dmand AI links 155 papers to Dr. Greicius, published from 2002 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Magnetic Resonance Imaging, Brain and Alzheimer Disease. Dr. Greicius has published most often in medRxiv. Dr. Greicius' most frequent co-authors are William R. Shirer, MD, Allan Leonard Reiss, MD and Euan Angues Ashley, MD.

Dmand AI links Dr. Greicius to 2 clinical trials. Conditions studied include Depressive Disorder, Hypopituitarism and Hypothalamic Diseases. Stanford University sponsors the most, 2.

Dmand AI lists 1 award for Dr. Greicius, most recently CMS Stage 1 EHR in 2013.

Dr. Greicius graduated from Vagelos College of Physicians and Surgeons in 1996.

Dr. Greicius is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.